NPK
National Presto Industries, Inc.
NPK has lower modeled downside risk, despite its lower overall score.
RKLB
Rocket Lab USA, Inc.
RKLB has the edge over NPK overall, supported by stronger valuation and stronger modeled upside.
NPK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
NPK's revenue, profitability, cash flow and balance sheet are all currently healthy.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
NPK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 14x | $85.32 | -39% |
| Fair | 19x | $112 | -20% |
| Current | 23x | $140 | — |
| Expensive | 24x | $146 | +4.2% |
Historical ranges are pointers, not guarantees.
NPK's PE is in its expensive range at 23x.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
NPK Forward outlook
There aren't enough analyst estimates for NPK to show an outlook.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
NPK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $5.98 | +2.4% |
| Q1 2026 | $4.49 | -25% |
| Q4 2025 | $4.63 | -20% |
| Q3 2025 | $5.45 | +15% |
| Q2 2025 | $5.84 | +27% |
| Q1 2025 | $5.97 | +32% |
| Q4 2024 | $5.82 | +20% |
| Q3 2024 | $4.75 | +43% |
NPK has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
NPK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $146.6M | +22% |
| Q1 2026 | $118.6M | +14% |
| Q4 2025 | $164M | +22% |
| Q3 2025 | $115.5M | +26% |
| Q2 2025 | $120.4M | +42% |
| Q1 2025 | $103.6M | +35% |
| Q4 2024 | $134.7M | +37% |
| Q3 2024 | $91.8M | +10% |
NPK's revenue has grown year over year for nine quarters in a row: $147M last quarter, up 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 13% | +8.2 points |
| Q1 2026 | 6.8% | -2 points |
| Q4 2025 | 11% | -6 points |
| Q3 2025 | 5.5% | -4.5 points |
| Q2 2025 | 5.1% | -2.4 points |
| Q1 2025 | 8.8% | +0.6 points |
| Q4 2024 | 17% | +3.8 points |
| Q3 2024 | 10% | +1.5 points |
NPK has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over NPK on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
NPK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $9.3M | +$22.7M |
| Q1 2026 | $29.4M | +$39.9M |
| Q4 2025 | $12.4M | +$23.7M |
| Q3 2025 | -$24.7M | -$4.4M |
| Q2 2025 | -$13.4M | +$21.3M |
| Q1 2025 | -$10.5M | -304% |
| Q4 2024 | -$11.3M | -169% |
| Q3 2024 | -$20.3M | -$15.2M |
NPK has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
NPK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.7x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | -0.0x | Net Cash |
| Q4 2024 | -0.4x | Net Cash |
| Q3 2024 | -0.4x | Net Cash |
NPK has more cash than debt.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NPK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.0 | Neutral |
| Stochastic | 49.6 | Neutral |
NPK's weekly RSI is 50 (neutral) and its Stochastic is 50 (neutral).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
NPK PE vs Industrials Sector
| Metric | NPK | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 24x | 2.5% below |
| PE % | 76 | 58 | 18 pts above |
NPK is trading at 23x earnings, in line with the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
NPK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $147.0 | 4.5% below |
| 20 week MA | $141.1 | 0.6% below |
| 50 week MA | $133.0 | 5.5% above |
| 100 week MA | $115.5 | 22% above |
| 200 week MA | $95.9 | 46% above |
NPK has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 46% above its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
NPK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $89.0 | $87.8 | -1.3% |
| 2021 | $87.8 | $82.2 | -6.4% |
| 2022 | $82.2 | $69.1 | -16% |
| 2023 | $69.1 | $80.3 | +16% |
| 2024 | $80.3 | $97.2 | +21% |
| 2025 | $97.2 | $108.5 | +12% |
| 2026 YTD | $108.5 | $140.3 | +29% |
NPK has the edge over RKLB on returns for 2026, with the stronger performance.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.